Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics CSBR

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Champions Oncology Inc

CSBR
Current price
8.36 USD +0.56 USD (+7.18%)
Last closed 7.80 USD
ISIN US15870P3073
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 121 814 992 USD
Yield for 12 month +69.92 %
1Y
3Y
5Y
10Y
15Y
CSBR
21.11.2021 - 28.11.2021

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey. Address: One University Plaza, Hackensack, NJ, United States, 07601

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.00 USD

P/E Ratio

19.58

Dividend Yield

Financials CSBR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+50 155 000 USD

Last Year

+53 870 000 USD

Current Quarter

+17 039 000 USD

Last Quarter

+13 489 000 USD

Current Year

+20 754 000 USD

Last Year

+24 338 000 USD

Current Quarter

+10 422 000 USD

Last Quarter

+6 417 000 USD
EBITDA 8 427 000 USD
Operating Margin TTM 26.40 %
Price to Earnings 19.58
Return On Assets TTM 14.64 %
PEG Ratio
Return On Equity TTM 37.68 %
Wall Street Target Price 12.00 USD
Revenue TTM 58 591 000 USD
Book Value 0.40 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 41.80 %
Dividend Yield
Gross Profit TTM 30 223 000 USD
Earnings per share 0.45 USD
Diluted Eps TTM 0.45 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -28.60 %
Profit Margin 10.97 %

Stock Valuation CSBR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 19.58
Forward PE 22.88
Enterprise Value Revenue 2.16
Price Sales TTM 2.08
Enterprise Value EBITDA 15.00
Price Book MRQ 22.53

Technical Indicators CSBR

For 52 Weeks

3.60 USD 11.99 USD
50 Day MA 6.88 USD
Shares Short Prior Month 95 869
200 Day MA 7.29 USD
Short Ratio 2.94
Shares Short 109 221
Short Percent 1.67 %